Skip to main navigation
Avadel Pharmaceuticals
  • Recent News
  • Investors
  • About
    • Overview
    • Leadership
    • Board of Directors
    • Business Development
    • Corporate Responsibility
  • Research
    • Clinical Trials
  • Contact Us
  • Call Today
  • Email Us
  • Our Map
    • Avadel Pharmaceuticals
    • 636.449.1830
    • Home
    • About
      • Overview
      • Leadership
      • Board of Directors
      • Business Development
      • Corporate Responsibility
    • Research Pipeline
      • Clinical Trials
    • Investor Relations

      • Investors
      • News & Events
        • Press Releases
        • Events
        • Presentations
      • Stock Information
        • Stock Quote & Chart
        • Historical Price Lookup
        • Investment Calculator
        • Analyst Coverage
      • Financial Information
        • SEC Filings
        • Financial Reports
        • Quarterly Results
      • Corporate Governance
        • Governance Highlights
        • Management Team
        • Board of Directors
        • Committee Composition
        • Annual General Meeting
      • Shareholder Services
        • Investor FAQs
        • Information Request
        • E-mail Alerts
        • IR Contacts
    • Contact Us
646.449.1830

Breadcrumb

  1. Home
  2. Investors
  3. SEC Filings

SEC Filings

SEC Filing Keyword Search

Filing date Form Description Filing Group Downloads
01/03/17 15-12G

15-12G    

Other
0000910680-17-000002.rtf
0000910680-17-000002.xls
0000910680-17-000002.pdf
01/04/17 25-NSE

25-NSE

Other
0001354457-17-000001.rtf
0001354457-17-000001.pdf
01/04/17 25-NSE/A

25-NSE/A

Other
0001354457-17-000004.rtf
0001354457-17-000004.pdf
01/04/17 8-K12B

8-K12B

Other
0001144204-17-000636.rtf
0001144204-17-000636.xls
0001144204-17-000636.pdf
01/06/17 8-K12B/A

8-K12B/A

Other
0001144204-17-000976.rtf
0001144204-17-000976.xls
0001144204-17-000976.pdf
06/02/16 PRE 14A

A preliminary proxy statement providing notification matters to be brought to a vote

Proxy Filings
0001144204-16-106544.rtf
0001144204-16-106544.xls
0001144204-16-106544.pdf
05/04/18 PRE 14A

A preliminary proxy statement providing notification matters to be brought to a vote

Proxy Filings
0001144204-18-025383.rtf
0001144204-18-025383.xls
0001144204-18-025383.pdf
04/16/20 PRE 14A

A preliminary proxy statement providing notification matters to be brought to a vote

Proxy Filings
0001104659-20-047632.rtf
0001104659-20-047632.xls
0001104659-20-047632.pdf
02/14/03 SC 13G

A statement of beneficial ownership of common stock by certain persons

Other
0000906344-03-000092.rtf
0000906344-03-000092.pdf
04/09/03 SC 13G

A statement of beneficial ownership of common stock by certain persons

Other
0001047469-03-012658.rtf
0001047469-03-012658.xls
0001047469-03-012658.pdf

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • …
  • Next page Next ›
  • Last page Last »

Tools

  • Print Page
  • RSS
  • E-mail Alerts

Investor Relations

  • Investors
  • News & Events
    • Press Releases
    • Events
    • Presentations
  • Stock Information
    • Stock Quote & Chart
    • Historical Price Lookup
    • Investment Calculator
    • Analyst Coverage
  • Financial Information
    • SEC Filings
    • Financial Reports
    • Quarterly Results
  • Corporate Governance
    • Governance Highlights
    • Management Team
    • Board of Directors
    • Committee Composition
    • Annual General Meeting
  • Shareholder Services
    • Investor FAQs
    • Information Request
    • E-mail Alerts
    • IR Contacts

Contact Avadel Pharmaceuticals Today

Avadel Pharmaceuticals

Helpful Links Site Map | Privacy Policy | Terms and Conditions

  • Overview
  • News & Events
  • Careers
  • Investors
  • Contact Us
16640 Chesterfield Grove Road,
Suite 200,
Saint Louis, MO 63005 |  View Map [+]
http://www.avadel.com/
Site Map | Privacy Policy
http://www.avadel.com/

© COPYRIGHT AVADEL PHARMACEUTICALS, PLC. ALL RIGHTS RESERVED

0117 AVL WBST MAIN_KP2